307 related articles for article (PubMed ID: 7594327)
21. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Miki I; Aoyama N; Sakai T; Shirasaka D; Wambura CM; Maekawa S; Kuroda K; Tamura T; Kita T; Sakaeda T; Okumura K; Kasuga M
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):27-33. PubMed ID: 12544691
[TBL] [Abstract][Full Text] [Related]
22. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
Maconi G; Russo A; Imbesi V; Cucino C; Bianchi Porro G
Dig Liver Dis; 2000 May; 32(4):275-80. PubMed ID: 11515622
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Niv Y
Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
[TBL] [Abstract][Full Text] [Related]
26. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
O'Morain C; Dettmer A; Rambow A; von Fritsch E; Fraser AG
Helicobacter; 1996 Sep; 1(3):130-7. PubMed ID: 9398893
[TBL] [Abstract][Full Text] [Related]
27. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739
[TBL] [Abstract][Full Text] [Related]
28. Eradication of Helicobacter pylori with lansoprazole, amoxicillin, and plaunotol in duodenal ulcer patients.
Shirai T; Takagi A; Kurumada T; Ohta U; Kobayashi H; Harasawa S; Miwa T
J Clin Gastroenterol; 1995; 20 Suppl 2():S128-31. PubMed ID: 7594329
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
Lamouliatte H; Perie F; Joubert-Collin M
Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
[TBL] [Abstract][Full Text] [Related]
31. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
32. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
33. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
35. Eradication of Helicobacter pylori with lansoprazole and clarithromycin.
Harris AW; Gummett PA; Logan RP; Ashworth HM; Baron JH; Misiewicz JJ
Aliment Pharmacol Ther; 1995 Apr; 9(2):201-4. PubMed ID: 7605863
[TBL] [Abstract][Full Text] [Related]
36. Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
Ishibashi S; Iwakiri R; Shimoda R; Ootani H; Kawasaki S; Tadano J; Kikkawa A; Ootani A; Oda K; Fujise T; Yoshida T; Tsunada S; Sakata H; Fujimoto K
Helicobacter; 2002 Aug; 7(4):245-9. PubMed ID: 12165032
[TBL] [Abstract][Full Text] [Related]
37. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
[TBL] [Abstract][Full Text] [Related]
38. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
39. The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.
Padol S; Yuan Y; Thabane M; Padol IT; Hunt RH
Am J Gastroenterol; 2006 Jul; 101(7):1467-75. PubMed ID: 16863547
[TBL] [Abstract][Full Text] [Related]
40. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
Lai YC; Wang TH; Huang SH; Yang SS; Wu CH; Chen TK; Lee CL
World J Gastroenterol; 2003 Jul; 9(7):1537-40. PubMed ID: 12854158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]